Vanguard Global Advisers’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
Vanguard Global Advisers's VCYT Position: Q3 2026 in Review
Vanguard Global Advisers increased its Veracyte (VCYT) stake by 7.5% in Q3 2026, buying an estimated $110K and bringing the position to 32,897 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1451.
Vanguard Global Advisers first reported a position in VCYT in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.8M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- Vanguard Global Advisers held 32,897 shares of Veracyte worth $1.51M as of Q3 2026.
- Vanguard Global Advisers bought 2,292 Veracyte shares in Q3 2026, an estimated $110K.
- Veracyte made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1451 holding.
- Vanguard Global Advisers first reported a position in Veracyte in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Veracyte position peaked at $1.8M in Q2 2026.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.